1.42 USD
▼-0.05-3.40%
盘后 1.75 0.00%
2026-09-16
市值
$1.02M
市盈率
—
EPS
-31.45
股息率
—
52 周区间
1.41 – 41.35
成交量
37.99K
Beta
1.40
目标价
13.25
52W 低 1.4152W 高 41.35
价格走势
公司简介
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.